药物对比
Fremanezumab vs Methysergide
Fremanezumab vs Methysergide for migraine: Ajovy CGRP mAb vs ergot. Safer modern option vs outdated drug with fibrosis risk.
此页面暂无可用的对比维度。
临床背景
Patients or clinicians comparing current CGRP-targeted therapies to historical ergot-based treatments for chronic migraine management.
结论
Fremanezumab is generally the better choice for migraine prevention due to its efficacy and safety compared to Methysergide.
全部药物对比